Sign In
Buy DGX
$193.67
+0.510 (+0.264%)
At Close: Jun 03, 2026
Quest Diagnostics (DGX) Collaborates With Broad Clinical Labs
12:26pm, Wednesday, 03'rd Apr 2024
Quest Diagnostics (DGX) collaboration is intended to demonstrate the clinical value of WGS as a first-line genetic test for postnatal diagnosis of developmental delay disorders.
Quest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome Sequencing as First-Line Genetic Test for Developmental Delay
07:57am, Tuesday, 02'nd Apr 2024
Aim to demonstrate whole genome sequencing can replace the standard diagnostic cascade, for potentially faster diagnosis and lower costs SECAUCUS, N.J. , April 2, 2024 /PRNewswire/ -- Quest Diagnosti
8 Upcoming Dividend Increases
09:11pm, Thursday, 28'th Mar 2024
A list of top stocks expected to raise dividends in the upcoming week, with increases averaging 8.4% and median 6.8%. Companies included in the list have consistently grown their dividends for at leas
Quest Diagnostics to Release First Quarter 2024 Financial Results on April 23, 2024
03:06pm, Tuesday, 19'th Mar 2024
SECAUCUS, N.J., March 19, 2024 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that it will report first quarter 2024 financial resul
Quest Diagnostics' (DGX) New Pact to Reduce Food Insecurity
01:21pm, Tuesday, 27'th Feb 2024
Quest Diagnostics' (DGX) recent collaboration aims to advance food access and healthy eating habits for underserved communities.
Quest Diagnostics to Speak at the Barclays 26th Annual Global Healthcare Conference
09:35am, Friday, 23'rd Feb 2024
SECAUCUS, N.J. , Feb. 23, 2024 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Sam Samad, Executive Vice President and Chief Fi
Quest Diagnostics (DGX) Boosts Oncology Portfolio With New Test
09:01am, Thursday, 15'th Feb 2024
Quest Diagnostics (DGX) debuts the MelaNodal Predict test in collaboration with SkylineDx.
Quest Diagnostics (DGX) Debuts PFAS Blood Test Offering
09:21am, Tuesday, 13'th Feb 2024
Quest Diagnostics (DGX) introduces the first consumer-initiated blood test with physician consult on questhealth.com.
3 Medtech Stocks Likely to Top Estimates This Earnings Season
08:51am, Tuesday, 13'th Feb 2024
Here are three stocks, GMED, GKOS and PRCT, which are expected to beat earnings estimates in the ongoing reporting cycle.
Reasons to Retain Quest Diagnostics (DGX) Stock for Now
08:16am, Tuesday, 06'th Feb 2024
Strength of the base business bodes well for Quest Diagnostics (DGX).
Quest Diagnostics: Post-COVID Normalization Pretty Much Done
05:36am, Monday, 05'th Feb 2024
Quest Diagnostics is a leading provider of diagnostic information services, offering laboratory testing, genomics, and other diagnostic solutions. During 2020, COVID-19 detection tests played an impor
Quest Diagnostics Inc. (DGX) Q4 2023 Earnings Call Transcript
11:42am, Thursday, 01'st Feb 2024
Quest Diagnostics Inc. (DGX) Q4 2023 Earnings Call Transcript
Quest Diagnostics (DGX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
10:37am, Thursday, 01'st Feb 2024
Although the revenue and EPS for Quest Diagnostics (DGX) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with
Quest Diagnostics (DGX) Q4 Revenues Top, Gross Margin Down
10:31am, Thursday, 01'st Feb 2024
Quest Diagnostics (DGX) delivers better-than-expected earnings and revenues in the fourth quarter of 2023.
Quest Diagnostics (DGX) Q4 Earnings and Revenues Beat Estimates
08:56am, Thursday, 01'st Feb 2024
Quest Diagnostics (DGX) came out with quarterly earnings of $2.15 per share, beating the Zacks Consensus Estimate of $2.14 per share. This compares to earnings of $1.98 per share a year ago.
